Windlas Biotech Limited

NSE:WINDLAS.NS

859.85 (INR) • At close September 19, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) INR.

2023202220212020201920182017
Operating Activities:
Net Income 581.87570.39455.65217.4246.68761.15111.98
Depreciation & Amortization 134.44123.64121.47129.6592.93105.91173.47
Deferred Income Tax 0-130.64-99.590000
Stock Based Compensation 20.6710.0818.130000
Change In Working Capital 439.5363.2-375.68-400.39-35.31-115.16-47.66
Accounts Receivables -198.35-83.63-316.73-148.35-26.06-9.75-8.23
Inventory 125.49-160.28-172.49100.7-302.9104.85105.2
Accounts Payables 437.68245.12233.04-460.39252-247.42-10.76
Other Working Capital 74.7161.99-119.5107.6541.6537.16-133.87
Other Non Cash Items -155.84-27.02-28.68167.88-54.24-565.36318.85
Operating Cash Flow 1,095.94609.6591.3114.54250.06186.54295.91
Investing Activities:
Investments In Property Plant And Equipment -376.84-708.9-148.04-58.47-153.1-89.54-257.82
Acquisitions Net 0.429.1-1,035-1,0350.14-1.836.11
Purchases Of Investments -561.67-369.08-147.43-147.43-0.14-29.460
Sales Maturities Of Investments 0882.281,022.151,022.150.3631.29137.83
Other Investing Activites -543.8445.5-1,237.4616.779.3336.8147.89
Investing Cash Flow -938.09-141.1-1,545.78-201.98-143.41-52.74-113.88
Financing Activities:
Debt Repayment -3.35-3.35-3.88-45.75-63.47-13.47-200.12
Common Stock Issued 01,6501,650-12.74048.150
Common Stock Repurchased -40.23-271.9300000
Dividends Paid -83.01-76.2800000
Other Financing Activities -13.33-1,735.83-345.2466.259.05-96.94-170.02
Financing Cash Flow -141.83-437.391,300.887.76-54.42-62.26-203.67
Other Information:
Effect Of Forex Changes On Cash 00058.20-14.9493.59
Net Change In Cash 272.5931.16-153.6-21.4852.2356.671.95
Cash At End Of Period 309.4536.865.7159.3180.78128.5571.95